Publications by authors named "L Habermehl"
Background: Status epilepticus (SE) is one of the most common neurological emergencies and an acutely life-threatening condition characterized by high mortality and morbidity. Despite the well-established staged therapy of status epilepticus, especially stages 1 and 2, more than one third of patients develop (super-) refractory SE. Despite a large variety of potential treatment options for super-refractory SE, there is an unmet clinical need of potential new treatment ideas in this often desperate clinical situation.
View Article and Find Full Text PDFObjective: Self-management interventions may enhance health-related quality of life (HRQoL) in epilepsy. However, several barriers often impair their implementation in the real world. Digital interventions may help to overcome some of these barriers.
View Article and Find Full Text PDFBackground: Seizure clusters, prolonged seizures, and status epilepticus are life-threatening neurological emergencies leading to irreversible neuronal damage. Benzodiazepines are current evidence-based rescue therapy options; however, recent investigations indicated the prescription of mainly unsuitable benzodiazepines and inappropriate use of rescue medication.
Objective: To examine current use, satisfaction, and adverse events concerning rescue medication in patients with epilepsy in Germany.
Objective: Brain tumors and metastases account for approximately 10% of all status epilepticus (SE) cases. This study described the clinical characteristics, treatment, and short- and long-term outcomes of this population.
Methods: This retrospective, multi-center cohort study analyzed all brain tumor patients treated for SE at the university hospitals of Frankfurt and Marburg between 2011 and 2017.
Article Synopsis
- The study examined the recurrence risk of seizures in elderly patients (60+) after their first unprovoked seizure, noting a recurrence rate of about 24.5% after one year and 34.4% after two years.
- It found that starting anti-seizure medication (ASM) significantly lowered the risk of recurrence, even in cases where no clear epileptogenic lesions or abnormal EEG results were present.
- The research suggests that factors like age and coexisting health issues influenced the decision to prescribe ASM, but did not directly impact the likelihood of seizure recurrence.